LivaNova (LIVN) Cost of Revenue (2014 - 2025)
LivaNova (LIVN) reported Cost of Revenue of $1.7 million for Q4 2025, down 98.38% on a YoY basis from $107.5 million in Q4 2024, and down 98.46% sequentially from $112.9 million in Q3 2025.
LivaNova (LIVN) Cost of Revenue (2014 - 2025) Analysis & Trends
LivaNova (LIVN) has 12 years of Cost of Revenue data on file, last reported at $1.7 million in Q4 2025.
- For the quarter ending Q4 2025, Cost of Revenue fell 98.38% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $116.3 million (down 44.1% YoY), and the FY2025 full-year result was $365.6 million, down 8.6% from the prior year.
- Cost of Revenue retreated to $1.7 million in Q4 2025, from $112.9 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $112.9 million in Q3 2025 to a low of -$262.3 million in Q4 2023.
- A 5-year average of $58.9 million and a median of $84.4 million in 2021 frame the typical range for Cost of Revenue.
- Across the five-year window, Cost of Revenue soared 2314.98% in 2021 and slumped 387.15% in 2023, its largest moves.
- Tracing LIVN's Cost of Revenue over 5 years: stood at $68.4 million in 2021, then jumped by 33.52% to $91.4 million in 2022, then tumbled by 387.15% to -$262.3 million in 2023, then jumped by 140.96% to $107.5 million in 2024, then sank by 98.38% to $1.7 million in 2025.
- Business Quant data shows LIVN's Cost of Revenue at $1.7 million in Q4 2025, $112.9 million in Q3 2025, and $1.7 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 4.89 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.21 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 12.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 362.60 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 441.60 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 481.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 2.51 Bn |
| 10 | LivaNova | 4.40 Bn | 3.86 Bn | 243.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.74 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Sep 30, 2025 | 112.90 Mn |
| Sep 30, 2025 | 112.90 Mn |
| Jun 30, 2025 | 1.68 Mn |
| Jun 30, 2025 | 1.68 Mn |
| Mar 31, 2025 | 100.60 Mn |
| Mar 31, 2025 | 100.60 Mn |
| Dec 31, 2024 | 107.46 Mn |
| Dec 31, 2024 | 107.46 Mn |
| Mar 31, 2024 | 91.70 Mn |
| Mar 31, 2024 | 91.70 Mn |
| Dec 31, 2023 | -262.33 Mn |
| Dec 31, 2023 | -262.33 Mn |
| Sep 30, 2023 | 84.31 Mn |
| Sep 30, 2023 | 84.31 Mn |
| Jun 30, 2023 | 88.69 Mn |
| Jun 30, 2023 | 88.69 Mn |
| Mar 31, 2023 | 89.34 Mn |
| Mar 31, 2023 | 89.34 Mn |